Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2026 Earnings Call Transcript May 5, 2026
Myriad Genetics, Inc. misses on earnings expectations. Reported EPS is $-0.09 EPS, expectations were $-0.06.
Operator: Good day and thank you for standing by. Welcome to the Myriad Genetics First Quarter 2026 Earnings Call. [Operator Instructions] Please be advised that today’s conference is being recorded. Now it’s my pleasure to hand the conference over to the Senior Vice President of Investor Relations, Matt...
